By Summit RCM |
Medicare is closely reviewing claims for collagen dressings, with 2024 data showing a 57.6% improper payment rate for surgical dressings and collagen audits reporting overpayment rates as high as 66.4%. Most denials happen due to missing or weak documentation rather than clinical errors under LCD L33831.
Collagen dressings are only covered when the wound meets Medicare criteria, and the chart clearly supports medical necessity.
This guide explains coverage of collagen dressings under LCD L33831, including qualifying wound types, HCPCS codes, PDAC requirements, documentation rules, ABN guidance, FY 2026 ICD-10 updates, and key billing mistakes to avoid.
LCD L33831 is Medicare’s Surgical Dressings Local Coverage Determination that defines when wound dressings, including collagen dressings, are considered medically necessary under the DMEPOS benefit.
The policy is administered nationwide by the four DME MAC contractors:
Every collagen dressing claim billed to Medicare Part B must comply with LCD L33831 requirements.
If documentation does not support medical necessity, the claim may be denied even if the patient clinically needed the dressing.
Defines:
Defines:
Defines:
Medicare only covers collagen dressings for qualifying wounds under LCD L33831.
The wound must be:
In addition, collagen coverage generally requires ALL of the following:
The wound must extend through the dermis into subcutaneous tissue or deeper.
Examples of covered wounds include:
Stage 1 and Stage 2 pressure injuries generally do not qualify because they are not full-thickness wounds.
The clinical note should specifically document:
Heavy exudate is considered a contraindication for collagen dressings under LCD L33831.
For heavily draining wounds, Medicare may instead expect alginate dressings such as:
One of the most important and most frequently underdocumented criteria is stalled healing.
A wound may qualify when:
The chart should clearly document:
Medicare commonly denies collagen dressing claims when:
Routine post-operative healing alone does not justify collagen dressing coverage.
Collagen dressings are recognized under Medicare because they support chronic wound healing through multiple biological mechanisms.
Clinical research shows collagen dressings may:
A 2022 meta-analysis of randomized controlled trials demonstrated positive outcomes for collagen dressings in:
This clinical evidence supports Medicare’s inclusion of collagen products under LCD L33831 when documentation supports medical necessity.
Collagen wound filler in dry form:
Billing basis: Per gram
PDAC validation is not required.
Collagen wound filler supplied as:
Billing basis: Per gram
PDAC validation is not required.
Collagen dressing sheets categorized by size.
Billing basis: Per piece
PDAC validation is required.
Collagen filler supplied as:
Billing basis: Per 6 inches
PDAC validation is required.
A6021–A6024 requires PDAC verification before billing Medicare.
If the collagen product is not listed on the PDAC-approved list, the claim may be denied regardless of clinical necessity.
A6010 and A6011 do not require PDAC validation because they are collagen fillers billed per gram.
The difference between A6010 and A6011 is based entirely on product formulation.
| HCPCS Code | Product Form | Billing Unit |
|---|---|---|
| A6010 | Powder/granules/beads | Per gram |
| A6011 | Gel/paste | Per gram |
The HCPCS code follows the product used — not the wound type.
Examples:
Medicare contractors routinely compare:
Code/product mismatches commonly trigger denials and audits.
Documentation failures account for the overwhelming majority of collagen dressing denials.
The SWO must include:
For shipped supplies, the Written Order before Delivery (WOPD) must be completed before shipment.
Each visit should document:
FY 2026 ICD-10 rules now require precise laterality documentation for lower-extremity wounds.
The note should explain WHY collagen was selected.
Examples:
The chart should document:
For dispensed supplies:
For in-office use:
Each follow-up visit should include:
Since October 1, 2025, Medicare has increased specificity requirements for wound coding.
Common ICD-10 codes supporting collagen dressings include:
| ICD-10 Code | Description |
|---|---|
| E11.621 | Type 2 diabetes with left foot ulcer |
| E11.622 | Type 2 diabetes with right foot ulcer |
| L89.313 | Stage 3 pressure ulcer right buttock |
| L89.314 | Stage 4 pressure ulcer right buttock |
| L97.312 | Chronic ulcer right ankle with fat exposed |
| I83.012 | Varicose ulcer right leg with fat exposed |
Claims using outdated non-lateralized codes increasingly trigger:
When a wound does not meet LCD L33831 criteria, providers must either:
Common ABN situations include:
Without a valid ABN, billing the patient may create compliance risk.
Collagen dressings remain a high-risk audit category under Medicare.
2024 improper payment findings showed:
This means documentation quality is the primary audit issue.
Claims may trigger:
Maintaining detailed wound documentation is critical for audit defence.
| Denial Reason | Cause | Prevention |
|---|---|---|
| Missing modifier | A1–A9 omitted | Add a modifier to every claim line |
| Insufficient medical necessity | Full-thickness wound not documented | Document wound depth and healing status |
| Product mismatch | Incorrect HCPCS code used | Build product-to-code crosswalk |
| Unsupported units | Grams not documented | Record the exact amount applied |
| Invalid ICD-10 coding | Missing laterality | Update FY 2026 coding templates |
Learn how to avoid costly mistakes in wound care billing by reviewing our detailed guide on common claim denial reasons in medical billing.
Full-thickness wound measuring [X] cm × [Y] cm × [Z] cm with exposed subcutaneous tissue. Exudate is [light/moderate]. The wound has not progressed despite [prior treatment] over [X] weeks. Collagen dressing selected to support extracellular matrix scaffold formation and chronic wound progression.
Applied [X] grams of collagen gel to full-thickness wound with light-to-moderate drainage. The wound demonstrates stalled healing despite conservative wound management. Product medically necessary under LCD L33831.
Before claim submission, confirm:
Explore how proper coding impacts payments in our guide on ICD-10 updates for wound care billing under Medicare FY 2026 rules.
Collagen dressing claims under Medicare LCD L33831 require accurate documentation, correct coding, and clear medical necessity. Even small gaps in wound depth, modifiers, or treatment history can lead to denials or audit risk.
Improving documentation consistency is key to better reimbursement and fewer claim issues in wound care billing.
If your practice is facing repeated denials, Summit RCM offers specialized wound care billing services to improve compliance, reduce denials, and strengthen Medicare reimbursement performance.
Contact Summit RCM to optimize your wound care billing process.
LCD L33831 is Medicare’s policy that defines when surgical dressings, including collagen dressings, are medically necessary and eligible for reimbursement under the DMEPOS benefit.
Medicare generally covers collagen dressings for full-thickness wounds such as diabetic foot ulcers, Stage 3–4 pressure ulcers, and chronic wounds with stalled healing and light to moderate drainage.
The most common reasons include missing wound depth documentation, incorrect HCPCS coding, absent A1–A9 modifiers, incomplete medical necessity notes, and lack of prior treatment history.
A6010 and A6011 do not require PDAC approval. PDAC validation is required for certain collagen dressing codes such as A6021 through A6024.
Denials can be reduced by ensuring complete wound documentation, correct code selection, proper modifier use, accurate ICD-10 coding, and clear medical necessity justification at every visit.
.png)